Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/1b/3a/7a/1b3a7a48-70b3-cb49-ae64-8221b0fa7623/mza_13362227464609804571.jpg/600x600bb.jpg
iMedicus Diabetes
imedicusdiabetes
14 episodes
7 months ago
Show more...
Medicine
Health & Fitness
RSS
All content for iMedicus Diabetes is the property of imedicusdiabetes and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/1b/3a/7a/1b3a7a48-70b3-cb49-ae64-8221b0fa7623/mza_13362227464609804571.jpg/600x600bb.jpg
Diabetes Update Podcast Series: Stroke in Diabetes - Ron Goldenberg, MD; Tess Fitzpatrick, MD
iMedicus Diabetes
14 minutes 31 seconds
3 years ago
Diabetes Update Podcast Series: Stroke in Diabetes - Ron Goldenberg, MD; Tess Fitzpatrick, MD
On this episode of the Diabetes Update 2022 podcast series titled ‘Stroke in Diabetes’, we are pleased to welcome Dr. Ron Goldenberg, consultant endocrinologist affiliated with North York General Hospital in Toronto, and LMC Diabetes and Endocrinology in Thornhill. We also welcome Dr Tess Fitzpatrick, a stroke neurologist, and a clinical stroke fellow at Sunnybrook Health Sciences Centre in Toronto. In this conversation, our guests discuss the pathophysiology and contributing factors leading up to stroke in patients with diabetes, as well as the Canadian Stroke Best Practice Guidelines for early screening, recognition, management, and prevention of stroke. Additionally, the episode discusses the importance of a comprehensive management approach to diabetes stroke prevention, including A1C control, cholesterol management, lifestyle modifications, and the role of GLP-1 RAs with proven stroke reduction benefit independent of patients' baseline A1C levels in managing multi-morbid cases. This program was made possible through funding from Lilly.
iMedicus Diabetes